|
| |
Gene LogicGene Logic aims to be the drug development partner of choice for the pharmaceutical and biotechnology industries by providing a unique portfolio of drug discovery and development solutions. Our capabilities span the drug development pipeline and address some of the most important issues in drug development today - productivity, safety, and enhancing late-stage pipelines. Gene Logic two business units are:
Drug Repositioning and Selection
Genomics Services
Through our Drug Repositioning and Selection™ (DRS™) Program, Gene Logic provides the pharmaceutical industry a unique cost-effective, low-risk partnering solution for finding new uses for their discontinued compounds, prioritizing the most promising lead candidates and finding the broadest therapeutic applications for a marketed compound lifecycle. Our partnerships are flexible, full service collaborations providing pharmaceutical companies the ability to share risk while working together to achieve success. Partners receive full access to our dedicated team of industry-leading drug developers and our comprehensive, multi-prong drug repositioning and selection technology platform.
Pharmaceutical and biotechnology companies worldwide trust Gene Logic's proven portfolio of Genomics Services to help accelerate their drug development process. Utilizing our scientific expertise and genomics informatics capabilities, we have built a portfolio of gene reference and clinical database systems, software, toxicity consulting services, as well as gene expression and genotyping microarray data generation outsourcing services, designed to meet a variety of economic needs and support applications for:
Microarray Reference Data Generation
Gene Expression Profiling
SNP Genotyping
Data Analysis Services
| Contact Details: |
| 50 West Watkins Mill Road |
| Gaithersburg |
| MD |
| 20878 |
| United States of America |
| Tel: | 301.987.1700 or 800.GENELOGIC (800.436.3564) |
| Fax: | 301.987.1701 |
| Email: | info@genelogic.com. |
| WWW: | www.genelogic.com/
|
|
Loading...
|
Recent Publications by Gene Logic: |  |
From pharmacogenomics to translational biomarkers.
There is a need for new biomarkers to enable faster detection of adverse... | 6th August, 2008
| Department of Toxicogenomics, Gene Logic Inc., Gaithersburg, Maryland,
| Methods Mol Biol. 2008;460:195-220.
DOI Direct Link |
In vivo predictive toxicogenomics.
Reference databases consisting of large sample numbers and... | 6th August, 2008
| Department of Toxicogenomics, Gene Logic Inc., Gaithersburg, Maryland,
| Methods Mol Biol. 2008;460:113-43.
DOI Direct Link |
Toxicogenomics and classic toxicology: how to improve prediction and mechanistic understanding of human toxicity.
The field of toxicogenomics has been advancing during the past decade or... | 6th August, 2008
| Department of Toxicogenomics, Gene Logic Inc., Gaithersburg, Maryland,
| Methods Mol Biol. 2008;460:1-22.
DOI Direct Link |
RNA--induced silencing of the plasma membrane Ca2+-ATPase 2 in neuronal cells: effects on Ca2+ homeostasis and cell viability.
Intraneuronal calcium ([Ca(2+)](i)) regulation is altered in aging brain,... | 8th September, 2007
| Gene Logic, Inc., Cambridge, Massachusetts, USA.
| J Neurochem. 2007 Jul;102(2):454-65. Epub 2007 May 4.
DOI Direct Link |
Current trends and strategic directions in the use of pharmacogenomics to identify translational biomarkers.
The development of new drugs is hampered by the quality and usefulness of... | 3rd April, 2007
| Gene Logic Inc, Toxicogenomics, 610 Professional Drive, Gaithersburg, MD
| Curr Opin Drug Discov Devel. 2007 Jan;10(1):37-42.
|
→View more Gene Logic research publications. |
Press Releases on Gene Logic:
|
 |
| Reportlinker Adds Bioinformatics - A Global Market Intelligence Report |
17th November, 2009 |
Reportlinker |
NEW YORK, Nov. 17 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
Bioinformatics - A Global Market Intelligence Report
http://www
|
| BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales |
29th June, 2009 |
BioStorage Technologies, Inc. |
INDIANAPOLIS, June 29 /PRNewswire/ -- BioStorage Technologies, Inc. (BST), a worldwide provider of long- and short-term storage of biomaterials, sample management and cold chain logistics, announces
|
| Genstruct and Gene Logic Collaborate on Systems Toxicology |
25th February, 2009 |
Genstruct Inc. |
SAN FRANCISCO, CAMBRIDGE, Mass. and GAITHERSBURG, Md., Feb. 25 /PRNewswire/ -- (CHI's Molecular Medicine Tri-Conference) - Genstruct Inc., a systems biology company focused on identifying
|
| Pharmacyclics, Inc. Announces Board and Management Transitions |
11th September, 2008 |
Pharmacyclics, Inc. |
SUNNYVALE, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc.
(the "Company" or "Pharmacyclics") announced today that Christine A. White,
M.D., Richard M. Levy Ph.D
|
| Solexa Announces Successful Closure of $14.4m financing |
1st May, 2003 |
Solexa |
Solexa
Announces Successful Closure of $14.4m financing
Cambridge,
UK
, and
Menlo Park
,
California
. September 28, 2004
Solexa
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 1050 times since April 2007, the link to the organisation's website has been followed 155 times Recent Search Terms used to find this page: Gene Logic capital | biostorage outsourcing uk | gene logic gene expression profiles | gene logics drug repositioning program | west watkins mill gaithersburg gene logics | west watkins mill gaithersburg gene logics | gene logic | drug repositioning venture capital | genelogic | toxicogenomic databases 2009 | . Search for more companies in Gaithersburg Search for more companies in MD This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Gene Logic |
